GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Bailing Group Pharmaceutical Co Ltd (SZSE:002424) » Definitions » Shiller PE Ratio

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Shiller PE Ratio : 20.70 (As of May. 27, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Guizhou Bailing Group Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-27), Guizhou Bailing Group Pharmaceutical Co's current share price is ¥4.14. Guizhou Bailing Group Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥0.20. Guizhou Bailing Group Pharmaceutical Co's Shiller PE Ratio for today is 20.70.

The historical rank and industry rank for Guizhou Bailing Group Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SZSE:002424' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.6   Med: 32.07   Max: 57.5
Current: 20.7

During the past years, Guizhou Bailing Group Pharmaceutical Co's highest Shiller PE Ratio was 57.50. The lowest was 20.60. And the median was 32.07.

SZSE:002424's Shiller PE Ratio is ranked better than
58.69% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.51 vs SZSE:002424: 20.70

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Guizhou Bailing Group Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.040. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.20 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Guizhou Bailing Group Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Guizhou Bailing Group Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Bailing Group Pharmaceutical Co Shiller PE Ratio Chart

Guizhou Bailing Group Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.91 29.34 29.76 32.53 41.07

Guizhou Bailing Group Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.96 36.13 32.49 41.07 37.96

Competitive Comparison of Guizhou Bailing Group Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhou Bailing Group Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guizhou Bailing Group Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhou Bailing Group Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Guizhou Bailing Group Pharmaceutical Co's Shiller PE Ratio falls into.



Guizhou Bailing Group Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Guizhou Bailing Group Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=4.14/0.2
=20.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guizhou Bailing Group Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Guizhou Bailing Group Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.04/115.2271*115.2271
=0.040

Current CPI (Mar. 2024) = 115.2271.

Guizhou Bailing Group Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.040 98.200 0.047
201409 0.010 98.900 0.012
201412 0.096 99.000 0.112
201503 0.070 99.900 0.081
201506 0.060 99.500 0.069
201509 0.040 100.500 0.046
201512 0.130 100.600 0.149
201603 0.080 102.200 0.090
201606 0.070 101.400 0.080
201609 0.070 102.400 0.079
201612 0.120 102.600 0.135
201703 0.100 103.200 0.112
201706 0.070 103.100 0.078
201709 0.070 104.100 0.077
201712 0.120 104.500 0.132
201803 0.110 105.300 0.120
201806 0.080 104.900 0.088
201809 0.090 106.600 0.097
201812 0.110 106.500 0.119
201903 0.110 107.700 0.118
201906 0.040 107.700 0.043
201909 0.060 109.800 0.063
201912 -0.010 111.200 -0.010
202003 0.060 112.300 0.062
202006 0.020 110.400 0.021
202009 0.040 111.700 0.041
202012 -0.010 111.500 -0.010
202103 0.040 112.662 0.041
202106 0.010 111.769 0.010
202109 0.030 112.215 0.031
202112 -0.010 113.108 -0.010
202203 0.050 114.335 0.050
202206 0.010 114.558 0.010
202209 0.010 115.339 0.010
202212 0.030 115.116 0.030
202303 0.070 115.116 0.070
202306 0.020 114.558 0.020
202309 0.010 115.339 0.010
202312 -0.400 114.781 -0.402
202403 0.040 115.227 0.040

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Guizhou Bailing Group Pharmaceutical Co  (SZSE:002424) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Guizhou Bailing Group Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Guizhou Bailing Group Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Business Description

Traded in Other Exchanges
N/A
Address
Economic and Technological Development Zone, Air Boulevard West, Anshun City, CHN, 561000
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company. It is engaged in the production and sale of medicinal tablets, capsules, and syrups.
Executives
Jiang Wei Director
Jiang Yong Directors, executives
Chen Pei Directors, executives
Kuang Xun Hua Director
Niu Min Directors, Directors, and Executives
Chen Zhi Securities Affairs Representative
Zheng Rong Executives
Li Qiang Supervisors
Xia Wen Supervisors
Wang Xiao Dong Supervisors
Teng Chun Jie Supervisors
Li Hui Fang Supervisors
Zhang Jin Fen Director
Cai Shou Xian Executives

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Headlines

No Headlines